1. Home
  2. NTHI vs SKYX Comparison

NTHI vs SKYX Comparison

Compare NTHI & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • SKYX
  • Stock Information
  • Founded
  • NTHI 2008
  • SKYX 2004
  • Country
  • NTHI United States
  • SKYX United States
  • Employees
  • NTHI N/A
  • SKYX N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • SKYX Building Products
  • Sector
  • NTHI Health Care
  • SKYX Consumer Discretionary
  • Exchange
  • NTHI Nasdaq
  • SKYX Nasdaq
  • Market Cap
  • NTHI 110.9M
  • SKYX 110.1M
  • IPO Year
  • NTHI N/A
  • SKYX 2022
  • Fundamental
  • Price
  • NTHI $5.10
  • SKYX $1.14
  • Analyst Decision
  • NTHI
  • SKYX Strong Buy
  • Analyst Count
  • NTHI 0
  • SKYX 2
  • Target Price
  • NTHI N/A
  • SKYX $3.50
  • AVG Volume (30 Days)
  • NTHI 284.4K
  • SKYX 834.3K
  • Earning Date
  • NTHI 01-01-0001
  • SKYX 08-11-2025
  • Dividend Yield
  • NTHI N/A
  • SKYX N/A
  • EPS Growth
  • NTHI N/A
  • SKYX N/A
  • EPS
  • NTHI N/A
  • SKYX N/A
  • Revenue
  • NTHI $79,990.00
  • SKYX $87,412,993.00
  • Revenue This Year
  • NTHI N/A
  • SKYX $18.78
  • Revenue Next Year
  • NTHI N/A
  • SKYX $29.23
  • P/E Ratio
  • NTHI N/A
  • SKYX N/A
  • Revenue Growth
  • NTHI 13.52
  • SKYX 12.42
  • 52 Week Low
  • NTHI $3.20
  • SKYX $0.80
  • 52 Week High
  • NTHI $25.00
  • SKYX $2.14
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • SKYX 54.68
  • Support Level
  • NTHI N/A
  • SKYX $1.04
  • Resistance Level
  • NTHI N/A
  • SKYX $1.15
  • Average True Range (ATR)
  • NTHI 0.00
  • SKYX 0.06
  • MACD
  • NTHI 0.00
  • SKYX 0.02
  • Stochastic Oscillator
  • NTHI 0.00
  • SKYX 88.76

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.

Share on Social Networks: